The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ASH 2020 | Lymphoma tumor microenvironment updates

Name: Lymphoma tumor microenvironment updates
Uploaded: 2020-12-04T00:00:00Z
Duration: 2 min 34 s
Description: Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MI, provides an overview of our current understanding of the tumor microenvironment. While there are now a variety of strategies used to target the tumor cell, Prof Ansell asserts that the future is going to be a combination of these. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.

Stephen Ansell • 4 Dec 2020

ASH 2020

Follicular Lymphoma Lymphoma Antibodies

Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MI, provides an overview of our current understanding of the tumor microenvironment. While there are now a variety of strategies used to target the tumor cell, Prof Ansell asserts that the future is going to be a combination of these. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.